Conference - Boston, MA, United States
This event is the only diabetes conference that provides delegates the opportunity to facilitate discussions and collaborations among affiliations (industry, academia, government) that can lead to the advancement of therapeutics and development of drugs/treatments for diabetes, and hopefully one day a cure. In addition the conference will provide updated educational research on various novel targets, therapeutics, developments, and technologies; regulatory guidance; case studies on successful and/or unsuccessful clinical trials; and other relevant insights that can help delegates advance their own research and therapeutics.
3rd Diabetes Partnering and Deal-making sessions:
Partnering & Licensing Strategies
Trends and Recent Deals
Recent Advances in Drug Design & Development
Type 2 Diabetes Innovation (Panel)
Data Analytics and Strategy Planning in Healthcare (Panel)
Investment and Mergers and Acquisitions in Diabetes (Panel)
Partnering and Licensing Strategies (Panel)
The Diabetes Summit 2013 consists of two concurrent tracks:
3rd Diabetes Partnering and Deal-making
6th Diabetes Drug Discovery and Development
(Courtesy of 1 Ave De Lafayette, Boston, MA 02111, Hotel location map, via travelocity.com)
Apr 29, 2013 to Apr 30, 2013
Hyatt Regency, 1 Ave De Lafayette, Boston, MA, USA
If you'd like to ask a question or post a comment about this talk please do so below.
This seminar posting is brought to you by Biotechnology Calendar, Inc. providing access to research information and research tools for nearly 20 years. Visit our Science Market Update Blog for current science funding and market information or see our schedule of upcoming science research laboratory product shows.
